{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:18:48Z","timestamp":1773872328979,"version":"3.50.1"},"reference-count":22,"publisher":"Japanese Pharmacological Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2010]]},"DOI":"10.1254\/jphs.10r07fm","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T05:20:17Z","timestamp":1281590417000},"page":"1-5","source":"Crossref","is-referenced-by-count":20,"title":["Advanced Research on Dopamine Signaling to Develop Drugs for the Treatment of Mental Disorders: Ser311Cys Polymorphisms of the Dopamine D2\u2013Receptor Gene and Schizophrenia"],"prefix":"10.1254","volume":"114","author":[{"given":"Masanari","family":"Itokawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadao","family":"Arinami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Toru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60:1187&ndash;1192.","DOI":"10.1001\/archpsyc.60.12.1187"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Sullivan PF. The genetics of schizophrenia. PLoS Med. 2005;2:e212.","DOI":"10.1371\/journal.pmed.0020212"},{"key":"3","unstructured":"3 Angrist BM, Gershon S. The phenomenology of experimentally induced amphetamine psychosis--preliminary observations. Biol Psychiatry. 1970;2:95&ndash;107."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Seeman P, Lee T, Chau-wong M, Wong K. Antipsychotic drug doses and neuroleptic\/dopamine receptors. Nature. 1976;261:717&ndash;719.","DOI":"10.1038\/261717a0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Marzella PL, Copolov D. [3H]nemonapride binding in human caudate and putamen. Brain Res Bull. 1997;44:167&ndash;170.","DOI":"10.1016\/S0361-9230(97)00105-6"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Seeman P, Guan HC, Van Tol HH. Dopamine D4 receptors elevated in schizophrenia. Nature. 1993;365:441&ndash;445.","DOI":"10.1038\/365441a0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60:1187&ndash;1192.","DOI":"10.1001\/archpsyc.60.12.1187"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Hashimoto K, Oyama T, Sugiyama T, Park Y, Kurita T. Neuronal excitation in the ventral tegmental area modulates the micturition reflex mediated via the dopamine D<SUB>1<\/SUB> and D<SUB>2<\/SUB> receptors in rats. J Pharmacol Sci. 2003;92:143&ndash;148.","DOI":"10.1254\/jphs.92.143"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Itokawa M, Arinami T, Futamura N, Hamaguchi H, Toru M. A structural polymorphism of human dopamine D2 receptor, D2(Ser311--&gt;Cys). Biochem Biophys Res Commun. 1993;196:1369&ndash;1375.","DOI":"10.1006\/bbrc.1993.2404"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Arinami T, Itokawa M, Enguchi H, Tagaya H, Yano S, Shimizu H, et al. Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet. 1994;343:703&ndash;704.","DOI":"10.1016\/S0140-6736(94)91581-4"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Crow TJ. Molecular pathology of schizophrenia: more than one disease process? Br Med J. 1980;280:66&ndash;68.","DOI":"10.1136\/bmj.280.6207.66"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Arinami T, Itokawa M, Aoki J, Shibuya H, Ookubo Y, Iwawaki A, et al. Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorders. Am J Med Genet. 1996;67:133&ndash;138.","DOI":"10.1002\/(SICI)1096-8628(19960409)67:2<133::AID-AJMG2>3.0.CO;2-T"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Lane HY, Lee CC, Chang YC, Lu CT, Huang CH, Chang WH. Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function. Int J Neuropsychopharmacol. 2004;7:461&ndash;470.","DOI":"10.1017\/S1461145704004389"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Shapiro RA, Nathanson NM. Deletion analysis of the mouse m1 muscarinic acetylcholine receptor: effects on phosphoinositide metabolism and down-regulation. Biochemistry. 1989;28:8946&ndash;8950.","DOI":"10.1021\/bi00448a039"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Maeda S, Lameh J, Mallet WG, Philip M, Ramachandran J, Sad&eacute;e W. Internalization of the Hm1 muscarinic cholinergic receptor involves the third cytoplasmic loop. FEBS Lett. 1990;269:386&ndash;388.","DOI":"10.1016\/0014-5793(90)81199-X"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Itokawa M, Toru M, Ito K, Tsuga H, Kameyama K, Haga T, et al. Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells. Mol Pharmacol. 1996;49:560&ndash;566.","DOI":"10.1016\/S0026-895X(25)08744-9"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Hausdorff WP, Caron MG, Lefkowitz RJ. Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J. 1990;4:2881&ndash;2889.","DOI":"10.1096\/fasebj.4.11.2165947"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Al-Fulaij MA, Ren Y, Beinborn M, Kopin AS. Pharmacological analysis of human D1 AND D2 dopamine receptor missense variants. J Mol Neurosci. 2008;34:211&ndash;223.","DOI":"10.1007\/s12031-007-9030-x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Glatt SJ, Faraone SV, Tsuang MT. Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia. Mol Psychiatry. 2003;8:911&ndash;915.","DOI":"10.1038\/sj.mp.4001321"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 J&ouml;nsson EG, Sill&eacute;n A, Vares M, Ekholm B, Terenius L, Sedvall GC. Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis. Am J Med Genet B Neuropsychiatr Genet. 2003;119B:28&ndash;34.","DOI":"10.1002\/ajmg.b.20004"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Glatt SJ, J&ouml;nsson EG. The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses. Am J Med Genet B Neuropsychiatr Genet. 2006;141B:149&ndash;154.","DOI":"10.1002\/ajmg.b.30273"},{"key":"22","unstructured":"22 SchizophreniaGene (SZGene) http:\/\/www.schizophreniaforum.org\/res\/sczgene\/default.asp"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:18:26Z","timestamp":1740377906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jphs\/114\/1\/114_10R07FM\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.10r07fm","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}